Purpose: To determine whether corneal cross-linking (CXL) with individualized fluence (“sub400 protocol”) is able to stop keratoconus (KC) progression in ultrathin corneas with 12-month follow-up. Design: Retrospective, interventional case series. Methods: Thirty-nine eyes with progressive KC and corneal stromal thicknesses from 214 to 398 μm at the time of ultraviolet irradiation were enrolled. After epithelium removal, ultraviolet irradiation was performed at 3 mW/cm2 with irradiation times individually adapted to stromal thickness. Pre- and postoperative examinations included corrected distance visual acuity (CDVA), refraction, Scheimpflug, and anterior segment optical coherence tomography imaging up to 12 months after CXL. Outcome measures were arrest of KC progression at 12 months postoperatively and stromal demarcation line (DL) depth. Results: Thirty-five eyes (90%) showed tomographical stability at 12 months after surgery. No eyes showed signs of endothelial decompensation. A significant correlation was found between DL depth and irradiation time (r = +0.448, P =.004) but not between DL depth and change in Kmax (r = −0.215, P =.189). On average, there was a significant change (P <.05) in thinnest stromal thickness (−14.5 ± 21.7 μm), Kmax (−2.06 ± 3.66 D) and densitometry (+2.00 ± 2.07 GSU). No significant changes were found in CDVA (P =.611), sphere (P =.077), or cylinder (P =.915). Conclusions: The “sub400” individualized fluence CXL protocol standardizes the treatment in ultrathin corneas and halted KC progression with a success rate of 90% at 12 months. The sub400 protocol allows for the treatment of corneas as thin as 214 μm of corneal stroma, markedly extending the treatment range. The DL depth did not predict treatment outcome. Hence, the depth is unlikely related to the extent of CXL-induced corneal stiffening but rather to the extent of CXL-induced microstructural changes and wound healing.

Hafezi, F., Kling, S., Gilardoni, F., Hafezi, N., Hillen, M., Abrishamchi, R., et al. (2021). Individualized Corneal Cross-linking With Riboflavin and UV-A in Ultrathin Corneas: The Sub400 Protocol. AMERICAN JOURNAL OF OPHTHALMOLOGY, 224, 133-142 [10.1016/j.ajo.2020.12.011].

Individualized Corneal Cross-linking With Riboflavin and UV-A in Ultrathin Corneas: The Sub400 Protocol

Mazzotta C.;
2021-01-01

Abstract

Purpose: To determine whether corneal cross-linking (CXL) with individualized fluence (“sub400 protocol”) is able to stop keratoconus (KC) progression in ultrathin corneas with 12-month follow-up. Design: Retrospective, interventional case series. Methods: Thirty-nine eyes with progressive KC and corneal stromal thicknesses from 214 to 398 μm at the time of ultraviolet irradiation were enrolled. After epithelium removal, ultraviolet irradiation was performed at 3 mW/cm2 with irradiation times individually adapted to stromal thickness. Pre- and postoperative examinations included corrected distance visual acuity (CDVA), refraction, Scheimpflug, and anterior segment optical coherence tomography imaging up to 12 months after CXL. Outcome measures were arrest of KC progression at 12 months postoperatively and stromal demarcation line (DL) depth. Results: Thirty-five eyes (90%) showed tomographical stability at 12 months after surgery. No eyes showed signs of endothelial decompensation. A significant correlation was found between DL depth and irradiation time (r = +0.448, P =.004) but not between DL depth and change in Kmax (r = −0.215, P =.189). On average, there was a significant change (P <.05) in thinnest stromal thickness (−14.5 ± 21.7 μm), Kmax (−2.06 ± 3.66 D) and densitometry (+2.00 ± 2.07 GSU). No significant changes were found in CDVA (P =.611), sphere (P =.077), or cylinder (P =.915). Conclusions: The “sub400” individualized fluence CXL protocol standardizes the treatment in ultrathin corneas and halted KC progression with a success rate of 90% at 12 months. The sub400 protocol allows for the treatment of corneas as thin as 214 μm of corneal stroma, markedly extending the treatment range. The DL depth did not predict treatment outcome. Hence, the depth is unlikely related to the extent of CXL-induced corneal stiffening but rather to the extent of CXL-induced microstructural changes and wound healing.
2021
Hafezi, F., Kling, S., Gilardoni, F., Hafezi, N., Hillen, M., Abrishamchi, R., et al. (2021). Individualized Corneal Cross-linking With Riboflavin and UV-A in Ultrathin Corneas: The Sub400 Protocol. AMERICAN JOURNAL OF OPHTHALMOLOGY, 224, 133-142 [10.1016/j.ajo.2020.12.011].
File in questo prodotto:
File Dimensione Formato  
Individualized Corneal Cross-linking-Hafezi-2021.pdf

non disponibili

Descrizione: Articolo
Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.07 MB
Formato Adobe PDF
1.07 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1178963